Clinical Trials Browser

Phase 2 × ceritinib × Head & Neck × Clear all

NCT02289144 2019-07-30

Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer

Phase 2 Withdrawn

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic